Global Hyperimmune Globulins Market Survey and Trend Research 2018

September 2018 | 72 pages | ID: GD7F9A024F8EN
99Strategy

Abstracts

Summary

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (CSL Behring, Grifols , Biotest, Kedrion, Emergent (Cangene), Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Hyperimmune Globulins Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HYPERIMMUNE GLOBULINS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 CSL Behring (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Grifols (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Biotest (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Kedrion (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Emergent (Cangene) (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Emergent (Cangene) (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Kamada (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 CNBG (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Hualan Bio (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Shanghai RAAS (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Sichuan Yuanda Shuyang (Company Overview, Sales Data etc.)
4.12 ADMA Biologics (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Hyperimmune Globulins Market 2012-2017, by Type, in USD Million
Table Global Hyperimmune Globulins Market Forecast 2018-2023, by Type, in USD Million
Table CSL Behring Overview List
Table Hyperimmune Globulins Business Operation of CSL Behring (Sales Revenue, Cost, Gross Margin)
Table Grifols Overview List
Table Hyperimmune Globulins Business Operation of Grifols (Sales Revenue, Cost, Gross Margin)
Table Biotest Overview List
Table Hyperimmune Globulins Business Operation of Biotest (Sales Revenue, Cost, Gross Margin)
Table Kedrion Overview List
Table Hyperimmune Globulins Business Operation of Kedrion (Sales Revenue, Cost, Gross Margin)
Table Emergent (Cangene) Overview List
Table Hyperimmune Globulins Business Operation of Emergent (Cangene) (Sales Revenue, Cost, Gross Margin)
Table Emergent (Cangene) Overview List
Table Hyperimmune Globulins Business Operation of Emergent (Cangene) (Sales Revenue, Cost, Gross Margin)
Table Kamada Overview List
Table Hyperimmune Globulins Business Operation of Kamada (Sales Revenue, Cost, Gross Margin)
Table CNBG Overview List
Table Hyperimmune Globulins Business Operation of CNBG (Sales Revenue, Cost, Gross Margin)
Table Hualan Bio Overview List
Table Hyperimmune Globulins Business Operation of Hualan Bio (Sales Revenue, Cost, Gross Margin)
Table Shanghai RAAS Overview List
Table Hyperimmune Globulins Business Operation of Shanghai RAAS (Sales Revenue, Cost, Gross Margin)
Table Sichuan Yuanda Shuyang Overview List
Table Hyperimmune Globulins Business Operation of Sichuan Yuanda Shuyang (Sales Revenue, Cost, Gross Margin)
Table ADMA Biologics Overview List
Table Hyperimmune Globulins Business Operation of ADMA Biologics (Sales Revenue, Cost, Gross Margin)
Table Global Hyperimmune Globulins Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Hyperimmune Globulins Sales Revenue Share, by Companies, in USD Million
Table Hyperimmune Globulins Demand 2012-2017, by Application, in USD Million
Table Hyperimmune Globulins Demand Forecast 2018-2023, by Application, in USD Million
Table Global Hyperimmune Globulins Market 2012-2017, by Region, in USD Million
Table Hyperimmune Globulins Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Hyperimmune Globulins Industry Chain Structure
Figure Global Hyperimmune Globulins Market Growth 2012-2017, by Type, in USD Million
Figure Global Hyperimmune Globulins Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region